ATE249241T1 - Immunologische zusammensetzungen und verfahren zur transienten änderung des zentralnervensystem- myelins der saügetiere und förderung der nerven- regenerierung - Google Patents
Immunologische zusammensetzungen und verfahren zur transienten änderung des zentralnervensystem- myelins der saügetiere und förderung der nerven- regenerierungInfo
- Publication number
- ATE249241T1 ATE249241T1 AT98949847T AT98949847T ATE249241T1 AT E249241 T1 ATE249241 T1 AT E249241T1 AT 98949847 T AT98949847 T AT 98949847T AT 98949847 T AT98949847 T AT 98949847T AT E249241 T1 ATE249241 T1 AT E249241T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- mammals
- nervous system
- central nervous
- nerve regeneration
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 102000006386 Myelin Proteins Human genes 0.000 title abstract 3
- 108010083674 Myelin Proteins Proteins 0.000 title abstract 3
- 210000005012 myelin Anatomy 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001737 promoting effect Effects 0.000 title abstract 2
- 230000008929 regeneration Effects 0.000 title abstract 2
- 238000011069 regeneration method Methods 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 210000003169 central nervous system Anatomy 0.000 title 1
- 230000001900 immune effect Effects 0.000 title 1
- 210000005036 nerve Anatomy 0.000 title 1
- 102000000989 Complement System Proteins Human genes 0.000 abstract 2
- 108010069112 Complement System Proteins Proteins 0.000 abstract 2
- 208000016192 Demyelinating disease Diseases 0.000 abstract 1
- 206010012305 Demyelination Diseases 0.000 abstract 1
- 230000009693 chronic damage Effects 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000001052 transient effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2219683 CA2219683A1 (en) | 1997-10-28 | 1997-10-28 | Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration |
| CA2251410 | 1998-10-16 | ||
| PCT/CA1998/000997 WO1999021581A1 (en) | 1997-10-28 | 1998-10-28 | Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE249241T1 true ATE249241T1 (de) | 2003-09-15 |
Family
ID=25679779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98949847T ATE249241T1 (de) | 1997-10-28 | 1998-10-28 | Immunologische zusammensetzungen und verfahren zur transienten änderung des zentralnervensystem- myelins der saügetiere und förderung der nerven- regenerierung |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6969516B1 (de) |
| EP (1) | EP1047449B1 (de) |
| JP (1) | JP2001521008A (de) |
| AT (1) | ATE249241T1 (de) |
| AU (1) | AU748143B2 (de) |
| DE (1) | DE69818106T2 (de) |
| DK (1) | DK1047449T3 (de) |
| ES (1) | ES2210829T3 (de) |
| IL (2) | IL135799A0 (de) |
| PT (1) | PT1047449E (de) |
| WO (1) | WO1999021581A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4095900A (en) * | 1999-04-28 | 2000-11-10 | University Of British Columbia, The | Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
| GB0103174D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Plc | Novel method of treatment |
| TWI323265B (en) * | 2002-08-06 | 2010-04-11 | Glaxo Group Ltd | Antibodies |
| GB0306309D0 (en) | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Method of treatment |
| SI3028716T1 (sl) | 2006-10-10 | 2021-01-29 | Regenesance B.V. | Komplementarna inhibicija za izboljšano regeneracijo živcev |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| TWI654206B (zh) | 2013-03-16 | 2019-03-21 | 諾華公司 | 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症 |
| US10058471B2 (en) * | 2014-02-21 | 2018-08-28 | William M. Vaughan | System and method of using hyperbaric oxygen therapy for treating concussive symptoms and musculoskeletal injuries and for pre-treatment to prevent damage from injuries |
| IL322264A (en) | 2014-04-07 | 2025-09-01 | Novartis Ag | Cancer treatment using chimeric antigen receptor (CAR) against CD19 |
| MX2017012939A (es) | 2015-04-08 | 2018-05-22 | Novartis Ag | Terapias cd20, terapias cd22 y terapias de combinacion con una celula que expresa un receptor quimerico de antigeno (car) de cd19. |
| WO2018067992A1 (en) | 2016-10-07 | 2018-04-12 | Novartis Ag | Chimeric antigen receptors for the treatment of cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002003A1 (en) * | 1989-08-04 | 1991-02-21 | Board Of Regents, The University Of Texas System | Methods and compositions; purified preparation of neural progenitor regulatory factor |
| US6020140A (en) * | 1991-08-09 | 2000-02-01 | Washington University | Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| NZ253867A (en) * | 1992-06-12 | 1996-08-27 | Cephalon Inc | Treating peripheral neuropathy using igf-1 or igf-3 |
| US5714385A (en) * | 1995-05-10 | 1998-02-03 | Genentech, Inc. | Media for culturing schwann cells |
| US6228598B1 (en) * | 1998-10-02 | 2001-05-08 | Washington University | Antibodies to heparan sulfate glycosaminoglycans in the diagnosis of polyneuropathies |
-
1998
- 1998-10-28 DK DK98949847T patent/DK1047449T3/da active
- 1998-10-28 AU AU96179/98A patent/AU748143B2/en not_active Ceased
- 1998-10-28 US US09/530,234 patent/US6969516B1/en not_active Expired - Fee Related
- 1998-10-28 DE DE69818106T patent/DE69818106T2/de not_active Expired - Lifetime
- 1998-10-28 EP EP98949847A patent/EP1047449B1/de not_active Expired - Lifetime
- 1998-10-28 AT AT98949847T patent/ATE249241T1/de not_active IP Right Cessation
- 1998-10-28 IL IL13579998A patent/IL135799A0/xx active IP Right Grant
- 1998-10-28 ES ES98949847T patent/ES2210829T3/es not_active Expired - Lifetime
- 1998-10-28 WO PCT/CA1998/000997 patent/WO1999021581A1/en not_active Ceased
- 1998-10-28 JP JP2000517739A patent/JP2001521008A/ja active Pending
- 1998-10-28 US US09/181,719 patent/US6548061B1/en not_active Expired - Fee Related
- 1998-10-28 PT PT98949847T patent/PT1047449E/pt unknown
-
2000
- 2000-04-24 IL IL135799A patent/IL135799A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL135799A (en) | 2011-01-31 |
| JP2001521008A (ja) | 2001-11-06 |
| US6969516B1 (en) | 2005-11-29 |
| WO1999021581A1 (en) | 1999-05-06 |
| PT1047449E (pt) | 2004-04-30 |
| US6548061B1 (en) | 2003-04-15 |
| EP1047449A1 (de) | 2000-11-02 |
| AU9617998A (en) | 1999-05-17 |
| DE69818106D1 (de) | 2003-10-16 |
| EP1047449B1 (de) | 2003-09-10 |
| IL135799A0 (en) | 2001-05-20 |
| AU748143B2 (en) | 2002-05-30 |
| DK1047449T3 (da) | 2004-01-26 |
| DE69818106T2 (de) | 2004-06-17 |
| ES2210829T3 (es) | 2004-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Narayanan et al. | Biosynthesis and regulation of type V collagen in diploid human fibroblasts. | |
| Vaghy et al. | Identification of a novel 1, 4-dihydropyridine-and phenylalkylamine-binding polypeptide in calcium channel preparations. | |
| DE69818106D1 (de) | Immunologische zusammensetzungen und verfahren zur transienten änderung des zentralnervensystem-myelins der saügetiere und förderung der nerven-regenerierung | |
| Barnes et al. | The collagen-platelet interaction | |
| Vaughan et al. | Proteoglycan Lt from chicken embryo sternum identified as type IX collagen. | |
| ATE137802T1 (de) | Monoklonaler antikörper, der mit einer neuen hla- determinante auf mhc-klasse-i-moleküle reagiert, und verfahren zur aktivierung von lymphozyten | |
| DE69732535D1 (de) | Oligonucleotidzusammenstellung und verfahren zur regulierung der protein b7 expression | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| ATE342962T1 (de) | Zusammensetzungen und verfahren für verbesserte zellkultur | |
| PT99770A (pt) | Processo para a preparacao de receptores de glutamato acoplados com proteina g de mamiferos | |
| DE68915675D1 (de) | Verfahren zur Reinigung von Vitamin K-abhängigen Proteinen. | |
| ATE171042T1 (de) | Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis | |
| ATE151113T1 (de) | Fusionsproteine von monomeren und dimeren von antikörperfragmenten | |
| NL300372I1 (nl) | Hybride immunoglobulinen voor gebruik bij therapeutische werkwijzen | |
| ATE403001T1 (de) | Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs | |
| MX7235E (es) | Procedimiento para preparar una solucion inyectable intravenosamente de globulina de suero inmune | |
| DE69939312D1 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
| DE3674642D1 (de) | Zur modifizierung von bitumen verwendbare polymerzusammensetzungen und so modifizierte bitumenmassen. | |
| KR910003094A (ko) | 흡혈박쥐속(Vampire bat) 타액 플라스미노겐 활성인자 | |
| YU47237B (sh) | Postupak za dobijanje smeša bitumen-polimera | |
| SE7909488L (sv) | Hemjernrikat aminosyrapreparat och forfarande for framstellning av hemjernrikade aminosyrapreparat fran hemproteiner | |
| Corces et al. | Binding of microtubule proteins to DNA: specificity of the interaction | |
| ATE136608T1 (de) | Verfahren zur herstellung von mischgut für strassendecken mittels zweifacher beschichtung | |
| EA199900522A1 (ru) | Полипептиды, кодируемые геном, подобным гену липазы человека, композиции и методы | |
| DE3689177D1 (de) | Verfahren zur Behandlung von Füllmaterialien und zur Konstruktion rutschfester Strassenoberflächen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1047449 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |